Floatz logo

AUTOLOGOUS CD34+ CELLS ENCODING .BETA.A-T87Q-GLOBIN GENE

Transfusion-dependent Beta-Thalassemia

Editas Medicine, Inc.Cell therapyPhase 1/2Active
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Transfusion-dependent Beta-Thalassemia cohort.

Asset / SponsorPhaseRating
Mitapivat
Agios Pharmaceuticals, Inc.
Phase 3B
kl003 cell
Kanglin Biotechnology (Hangzhou) Co., Ltd.
Phase 1/2CCC

Same molecule, other indications

AUTOLOGOUS CD34+ CELLS ENCODING .BETA.A-T87Q-GLOBIN GENE is also rated in:

beta thalassemiaDormant
B
Indicative ·
60 / 100
View asset →
beta-thalassemia majorDormant
CCC
Indicative ·
55 / 100
View asset →
sickle cell diseaseDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →